These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18655946)

  • 1. Antibiotics in the intensive care unit: focus on agents for resistant pathogens.
    Volles DF; Branan TN
    Emerg Med Clin North Am; 2008 Aug; 26(3):813-34, x. PubMed ID: 18655946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of antibiotic resistance in the intensive care unit setting.
    Petrosillo N; Capone A; Di Bella S; Taglietti F
    Expert Rev Anti Infect Ther; 2010 Mar; 8(3):289-302. PubMed ID: 20192683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-negative bacterial resistance: evolving patterns and treatment paradigms.
    Kollef MH
    Clin Infect Dis; 2005 Feb; 40 Suppl 2():S85-8. PubMed ID: 15712101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy.
    Paterson DL
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S14-20. PubMed ID: 18713045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in antibacterial therapy against emerging bacterial pathogens.
    Pournaras S; Iosifidis E; Roilides E
    Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New therapeutic options for the treatment of multiresistant bacteria in the ICU].
    Barcenilla Gaite F; Jover Saenz A; Vallverdú Vidal M; Castellana Perello D
    Rev Esp Quimioter; 2008; 21 Spec No 1():9-13. PubMed ID: 18752075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic use and antibiotic resistance in the intensive care unit: are we curing or creating disease?
    Kollef MH
    Heart Lung; 1994; 23(5):363-7. PubMed ID: 7989204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance: how it arises, the current position and strategies for the future.
    Perry C; Hall C
    Nurs Times; 2009 Sep 15-21; 105(36):20-3. PubMed ID: 19835196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center - 6 years' experience.
    Lee CY; Chen PY; Huang FL; Lin CF
    J Microbiol Immunol Infect; 2009 Apr; 42(2):160-5. PubMed ID: 19597649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model of the transmission of antibiotic-resistant bacteria in the intensive care unit.
    Barza M
    New Horiz; 1996 Aug; 4(3):333-7. PubMed ID: 8856750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the epidemiological situation and the resistance phenotype of pathogens isolated from patients in the intensive care unite of the Lodz Medical University Hospital No.1 in 2002-2006].
    Bartoszko-Tyczkowska A; Gaszyński W; Tyczkowska-Sieroń E
    Med Dosw Mikrobiol; 2008; 60(3):223-30. PubMed ID: 19143176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of antibiotic resistance.
    Gould IM
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S2-9. PubMed ID: 18757182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving pathogens in the surgical intensive care unit: a 6-year experience.
    Starnes MJ; Brown CV; Morales IR; Hadjizacharia P; Salim A; Inaba K; Rhee P; Demetriades D
    J Crit Care; 2008 Dec; 23(4):507-12. PubMed ID: 19056014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single versus combination antimicrobial therapy for ventilator-associated pneumonia.
    Malangoni MA
    Am J Surg; 2000 Feb; 179(2A Suppl):58S-62S. PubMed ID: 10802268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microbial spectrum in surgical infections based on a microbiological routine monitoring over the 10-year period from 1995 to 2004].
    Mroczkowski P; Lauf H; Lippert H; König W; Meyer F
    Zentralbl Chir; 2009 Jun; 134(3):226-30. PubMed ID: 19536716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.